Suchergebnisse - "Krijgsman, Oscar"

1

Detection limits of DNA copy number alterations in heterogeneous cell populations

von: Krijgsman, Oscar

2012, in: Cellular oncology

Wird geladen...
2

A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response

von: Krijgsman, Oscar

2011, in: Breast cancer research and treatment

Wird geladen...
3

Focal chromosomal copy number aberrations in cancer—Needles in a genome haystack

von: Krijgsman, Oscar

2014transfer abstract, in: Modal analysis using camera-based heterodyne interferometry and acoustic excitation

Wird geladen...
4

Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses

von: van Wieringen, Wessel N

2012, in: BMC bioinformatics

Wird geladen...
5

Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses

von: van Wieringen Wessel N

2012, in: BMC Bioinformatics

Wird geladen...
6

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors

von: Azimi, Alireza

2018, in: Molecular Systems Biology

Wird geladen...
7

CopywriteR: DNA copy number detection from off-target sequence data

von: Kuilman, Thomas

2015, in: Genome biology

Wird geladen...
8

Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts

von: Kemper, Kristel

2015, in: EMBO Molecular Medicine

Wird geladen...
9

XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data

von: Kluin, Roelof J. C.

2018, in: BMC bioinformatics

Wird geladen...
10

Genomic aberrations relate early and advanced stage ovarian cancer

von: Zaal, Afra

2012, in: Cellular oncology

Wird geladen...
11

Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms

von: Schouten, Philip C.

2015transfer abstract, in: Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced CKD

Wird geladen...
12

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

von: Rozeman, Elisa A

2019, in: The lancet / Oncology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!